Connect with us

Business

Descheduling Marijuana – The Holy Grail of the Cannabis Industry Gets a Bipartisan Push to President Biden

Published

on

Republicans and Democrats push Biden to Deschedule Marijuana from the CSA

While the Biden administration investigates marijuana’s federal scheduling, a bipartisan group of congressional members is urging the president to openly support outright legalization. Recently, a letter which is slated to be addressed to President Joe Biden and key cabinet officials was obtained by Marijuana Moment.

The Congressmen stated in the letter that while they applaud the directive of the scheduling review, the administration should embrace the virtues of full descheduling. The letter states that while the congressmen don’t always agree on specific policies, they realize across the aisle that prolonged federal criminalization and prohibition of cannabis do not mirror the desires of the larger American population. It is past time for the Biden administration’s agenda to adequately reflect this reality.

As Politico first reported, current signatories, include Congressional Cannabis Caucus co-chairs Reps. Earl Blumenauer (D-OR), and Sen. Elizabeth Warren (D-MA), Dave Joyce (R-OH), Brian Mast (R-FL), and Barbara Lee (D-CA). More signatures will still be needed before the letter is finished in the following days.

In their letter to the president, the lawmakers explained that cannabis does not belong in the Controlled Substances Act Schedule I class. The class is reserved for exceedingly dangerous substances with a high potential for misuse and no medicinal purpose. The decision to schedule cannabis was based on stigma rather than evidence, and it is time to right this injustice.

According to the letter, descheduling cannabis can uphold state and federal power to regulate cannabis while simultaneously granting states the right to continue criminalizing cannabis production and sales. The letter also notes that the House has twice supported proposals to federally legalize, regulate and tax cannabis.

Additionally, discriminatory scheduling of cannabis and standardizing federal cannabis regulations go hand-in-hand—like eliminating prohibitions and placing a greater burden on researchers trying to study cannabis relative to other Schedule I drugs. The federal government must end this criminalization and ban otherwise legal marijuana.

This will allow meaningful research to progress, creating legal employment opportunities, promoting public safety rather than unjust incarceration, and preserving established government oversight of cannabis taxation, production, and sales. The letter further explains that the need for federal guidance and legislative action on many of these facets must be considered. Still, all sections of the federal government must acknowledge the importance of the descheduling of cannabis. These federal sections also need to do so in a way that respects state sovereignty, the markets and laws within each state’s purview to establish.

The coalition is distributing this letter as leaders in congress race against time to pass more constricted cannabis banking and expungement legislation during the lame-duck session.

A Last Ditch Effort

According to a senior Senate Democratic aide, Senate Majority Leader Chuck Schumer (D-NY) is “making a last-ditch effort” to incorporate the incremental reform in impending omnibus appropriations legislation. However, key figures like Sen. John Cornyn (R-TX) and Senate Minority Leader Mitch McConnell (R-KY) have been obstacles.

Advocates would obviously want to see greater legalization adopted sooner rather than later. Still, it has become clear that the Senate needs more backing to secure the requisite 60 votes for approval. The letter to Biden does not necessarily request that he take unilateral action to repeal the prohibition. Still, his support for the issue may make a significant difference. So far, the president has supported decriminalization and allowing states to choose their own rules. Still, he has been unwilling to endorse federal legalization.

The coalition claims that descheduling is required to eliminate the damaging federal cannabis prohibition and assist law enforcement officials in giving the public’s safety the priority it deserves. Descheduling also creates an opportunity for taxing and regulating commercial cannabis activity, which is the most practical way to alleviate the legal uncertainties that small businesses face in jurisdictions with regulated cannabis markets.

The coalition anticipates that the Departments of Justice and Health and Human Services will continue to work quickly to carry out your ordered review of marijuana’s scheduling. The importance of full descheduling should guide the Administration’s approach to comprehensive cannabis reform. At the same time, Congress works to give you comprehensive cannabis legislation. The continual inappropriate scheduling of marijuana is both esoteric and out of step with what the American people want. To take this important action, the coalition hopes the Biden Administration will cooperate openly and constructively with Congress.

A Reply To The Undated Letter

CCed on the undated letter is U.S. Secretary of Health and Human Services (HHS) Xavier Becerra, who recently tweeted a hyperlink to a Marijuana Moment article about the president’s administrative cannabis scheduling policy. “We’re going to evaluate what scientific evidence tells us,” said Becerra, a former congressman and California attorney general who has long advocated for cannabis legalization, at a recent overdose prevention conference. “That will guide our actions, and we hope it will guide the actions of the federal government.”

Following the president’s announcement of cannabis pardons and scheduling, the secretary stated that the department would act as swiftly as possible to complete the scientific study. He also mentioned that there’s been a discussion with the commissioner of the Food and Drug Administration (FDA). The congressmen’s letter is also CCed to Attorney General Merrick Garland, whose Department of Justice oversees the scheduling review.

Meanwhile, the White House drug czar recently stated that the president’s action was “historic,” and that cannabis has obvious medical benefits. Like HHS, the DOJ has committed to expediting the separate scheduling study requested by the president, which may result in a proposal to place cannabis on a lower schedule or remove it entirely, thus legalizing cannabis under federal law.

Conclusion

Furthermore, following his federal clemency action, Biden recently applauded the governor of Oregon’s decision to pardon thousands of marijuana offenders this month. Additionally, he advises other states to “follow Oregon’s example. This month, the president also formally enacted the nation’s first separate federal cannabis reform law by signing a bill on marijuana research into law.

Numerous polls have also revealed that Americans firmly support the president’s pardon decision. These polls also show that Americans don’t believe marijuana should be listed as a Schedule I substance by the federal government.

Source: https://cannabis.net/blog/news/descheduling-marijuana-the-holy-grail-of-the-cannabis-industry-gets-a-bipartisan-push-to-presid

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Business

Marijuana companies suing US attorney general in federal prohibition challenge

Published

on

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.

According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”

Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.

The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”

The companies want the case to go before the U.S. Supreme Court.

They hired prominent law firm Boies Schiller Flexner to represent them.

The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.

Similar challenges to the federal Controlled Substances Act (CSA) have failed.

One such challenge led to a landmark Supreme Court decision in 2005.

In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.

In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.

Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.

“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.

“Moreover, the facts on which those precedents are based are no longer true.”

Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”

While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.

“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”

Source: https://mjbizdaily.com/marijuana-companies-suing-us-attorney-general-to-overturn-federal-prohibition/

Continue Reading

Business

Alabama to make another attempt Dec. 1 to award medical cannabis licenses

Published

on

Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.

The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).

Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.

Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.

That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.

Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.

Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.

A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.

Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News